ACTI-STREPTO
ACTI-STREPTO
Authorised
- Dihydrostreptomycin sulfate
Product identification
Medicine name:
ACTI-STREPTO
Active substance:
- Dihydrostreptomycin sulfate
Target species:
-
Cattle
-
Pig
-
Rabbit
-
Cattle (calf)
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Dihydrostreptomycin sulfate626.00/milligram(s)1.00gram(s)
Pharmaceutical form:
-
Powder for oral solution
Withdrawal period by route of administration:
-
Oral use
- Cattle
-
Milkno withdrawal periodLa spécialité n'est pas destinée aux femelles laitières productrices de lait de consommation.
-
- Pig
-
Meat and offal14day
-
- Rabbit
-
Meat and offal14day
-
- Cattle (calf)
-
Meat and offal14day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QA07AA90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
France
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
- Laboratoires Biove
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratoires Biové
Responsible authority:
- French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
- FR/V/2441413 9/1992
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
French (PDF)
Published on: 4/04/2022
How useful was this page?:
